96 related articles for article (PubMed ID: 2355640)
1. [Clinical significance of CA 130 assay as a tumor marker].
Ariyoshi Y; Kuwabara M
Nihon Rinsho; 1990 Feb; 48 Suppl():985-8. PubMed ID: 2355640
[No Abstract] [Full Text] [Related]
2. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
Sugano K; Okura H
Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
[No Abstract] [Full Text] [Related]
3. [Clinical significance of CA 195 assay as a tumor marker].
Ohkura H; Sakawaki T
Nihon Rinsho; 1990 Feb; 48 Suppl():982-4. PubMed ID: 2355639
[No Abstract] [Full Text] [Related]
4. [Clinical significance of CA125 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Kuzuya K
Nihon Rinsho; 1990 Feb; 48 Suppl():978-81. PubMed ID: 2192183
[No Abstract] [Full Text] [Related]
5. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
Miladinović D; Paunović R; Paunković N
Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of TAC-41 assay as a tumor marker].
Ariyoshi Y; Kuwabara M; Iwakoshi N; Kito K
Nihon Rinsho; 1990 Feb; 48 Suppl():1060-3. PubMed ID: 2162412
[No Abstract] [Full Text] [Related]
7. [Clinical significance of CA 15-3 assay as a tumor marker].
Goto M; Adachi I
Nihon Rinsho; 1990 Feb; 48 Suppl():967-70. PubMed ID: 2355637
[No Abstract] [Full Text] [Related]
8. [Clinical significance of CA 72-4 assay as a tumor marker].
Konishi F
Nihon Rinsho; 1990 Feb; 48 Suppl():974-7. PubMed ID: 2355638
[No Abstract] [Full Text] [Related]
9. [Clinical applications of CA 125 carcinoma of the ovary].
Tomioka E; Fujita MM; Izaki M; Lin WF; Moriyama AJ; Bastos Ada C
Rev Paul Med; 1991; 109(3):123-30. PubMed ID: 1947608
[TBL] [Abstract][Full Text] [Related]
10. [CA-125 values in fluid and serum in females with cystic ovarian tumors].
Sautter T; Mickan H
Gynakol Rundsch; 1990; 30 Suppl 1():208-9. PubMed ID: 2079272
[No Abstract] [Full Text] [Related]
11. [Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].
Shimano T; Morimoto H; Saito M; Mori T
Nihon Rinsho; 1990 Feb; 48 Suppl():917-9. PubMed ID: 2192174
[No Abstract] [Full Text] [Related]
12. Adjunctive measurement to CA 125 marker found.
Oncology (Williston Park); 1991 Dec; 5(12):64. PubMed ID: 1840026
[No Abstract] [Full Text] [Related]
13. [Tumor markers for ovarian cancers].
Aoki D; Kataoka F; Susumu N; Nozawa S
Nihon Rinsho; 2004 Oct; 62 Suppl 10():496-502. PubMed ID: 15535295
[No Abstract] [Full Text] [Related]
14. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
[No Abstract] [Full Text] [Related]
15. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
16. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
17. [A CA 12-5 prognostic score for epithelial ovarian cancers].
Klein M; Rosen A; Sevelda P; Spona J; Beck A
Gynakol Rundsch; 1990; 30 Suppl 1():70-2. PubMed ID: 2079305
[No Abstract] [Full Text] [Related]
18. [Significance of the the tumor markers, Ca-125 and tumor-associated trypsin inhibitor in patients with carcinoma of the cervix and uterus].
Ilić RS; Mihailović D
Srp Arh Celok Lek; 1992; 120(3-4):97-9. PubMed ID: 1465666
[TBL] [Abstract][Full Text] [Related]
19. [Value of biological markers in the diagnosis and monitoring of cystadenocarcinoma].
Bidart JM; Bellet D
Rev Prat; 1989 Nov; 39(26):2317-20. PubMed ID: 2595221
[TBL] [Abstract][Full Text] [Related]
20. [Does follow-up of false-negative CA-125 serum values in tumor after-care of ovarian cancer make sense?].
Sevelda P; Rosen A; Barrada M; Gober S; Vavra N; Salzer H
Gynakol Rundsch; 1990; 30 Suppl 1():210-1. PubMed ID: 2079273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
